Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Inoue

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|May 28, 2024
3-Fr steerable microcatheter system via the upper limb artery in RADPLAT for right maxillary cancerMasao Takahashi, Ken Nakazawa, Yoko Usami, et al.
Scientific Reports|October 28, 2021
FAN score comprising fibrosis-4 index, albumin-bilirubin score and neutrophil-lymphocyte ratio is a prognostic marker of urothelial carcinoma patients treated with pembrolizumabAtsunari Kawashima, Yoshiyuki Yamamoto, Mototaka Sato, et al.
Nature Communications|July 19, 2024
Pseudoirreversible inhibition elicits persistent efficacy of a sphingosine 1-phosphate receptor 1 antagonistYuya Maruyama, Yusuke Ohsawa, Takayuki Suzuki, et al.
Journal of Gastrointestinal Oncology|May 10, 2021
Conversion surgery in patients with pancreatic cancer and peritoneal metastasisSuguru Yamada, Tsutomu Fujii, Tomohisa Yamamoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2003
[Hormonal chemotherapy for hormone-refractory prostate cancer]Kazuo Nishimura, Yasutomo Nakai, Kiyonori Shimizu, et al.
Journal of Surgical Case Reports|August 19, 2021
Ruptured metastatic liver tumor secondary to a thymoma: a case reportTakeshi Utsunomiya, Katsunori Sakamoto, Daiki Tsukamoto, et al.
Japanese Journal of Clinical Oncology|February 2, 2024
Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC studyAkira Nagahara, Motohide Uemura, Mototaka Sato, et al.
International Journal of Hematology|January 4, 2020
High-dose dexamethasone therapy as the initial treatment for idiopathic thrombocytopenic purpuraKen Takase, Hirokazu Nagai, Moe Kadono, et al.
International Journal of Clinical Oncology|September 2, 2024
Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in JapanAkihiro Yoshimura, Taigo Kato, Yasutomo Nakai, et al.
Cancer Treatment and Research Communications|May 29, 2026
Neutrophil-to-lymphocyte ratio and performance status are associated with increased risk of skin toxicity in patients receiving enfortumab vedotin with or without pembrolizumab for metastatic urothelial carcinomaYujiro Hayashi, Atsunari Kawashima, Yoshiyuki Yamamoto, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|May 28, 2024
3-Fr steerable microcatheter system via the upper limb artery in RADPLAT for right maxillary cancerMasao Takahashi, Ken Nakazawa, Yoko Usami, et al.
Scientific Reports|October 28, 2021
FAN score comprising fibrosis-4 index, albumin-bilirubin score and neutrophil-lymphocyte ratio is a prognostic marker of urothelial carcinoma patients treated with pembrolizumabAtsunari Kawashima, Yoshiyuki Yamamoto, Mototaka Sato, et al.
Nature Communications|July 19, 2024
Pseudoirreversible inhibition elicits persistent efficacy of a sphingosine 1-phosphate receptor 1 antagonistYuya Maruyama, Yusuke Ohsawa, Takayuki Suzuki, et al.
Journal of Gastrointestinal Oncology|May 10, 2021
Conversion surgery in patients with pancreatic cancer and peritoneal metastasisSuguru Yamada, Tsutomu Fujii, Tomohisa Yamamoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2003
[Hormonal chemotherapy for hormone-refractory prostate cancer]Kazuo Nishimura, Yasutomo Nakai, Kiyonori Shimizu, et al.
Journal of Surgical Case Reports|August 19, 2021
Ruptured metastatic liver tumor secondary to a thymoma: a case reportTakeshi Utsunomiya, Katsunori Sakamoto, Daiki Tsukamoto, et al.
Japanese Journal of Clinical Oncology|February 2, 2024
Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC studyAkira Nagahara, Motohide Uemura, Mototaka Sato, et al.
International Journal of Hematology|January 4, 2020
High-dose dexamethasone therapy as the initial treatment for idiopathic thrombocytopenic purpuraKen Takase, Hirokazu Nagai, Moe Kadono, et al.
International Journal of Clinical Oncology|September 2, 2024
Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in JapanAkihiro Yoshimura, Taigo Kato, Yasutomo Nakai, et al.
Cancer Treatment and Research Communications|May 29, 2026
Neutrophil-to-lymphocyte ratio and performance status are associated with increased risk of skin toxicity in patients receiving enfortumab vedotin with or without pembrolizumab for metastatic urothelial carcinomaYujiro Hayashi, Atsunari Kawashima, Yoshiyuki Yamamoto, et al.
Pageof 12